Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M143Revenue $M0Net Margin (%)0Z-Score1.8
Enterprise Value $M65.9EPS $-1.2Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %0Quick Ratio20.3Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio20.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-34.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.3ROI % (ttm)-69.7Gross Margin Increase y-yN

Gurus Latest Trades with CNDO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CNDOGeorge Soros 2014-09-30 Sold Out $1.48 - $2.16
($1.77)
$ 3.2382%Sold Out0
CNDOGeorge Soros 2014-06-30 Buy $1.55 - $2.02
($1.76)
$ 3.2384%New holding, 29279 sh.29,279
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CNDO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CNDO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lu LucyCFO 2014-12-01Buy5,000$1.45122.76view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-12-01Buy974$1.45122.76view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-11-06Buy150,000$1.61100.62view
Hoenlein MalcolmDirector 2014-11-06Buy25,000$1.61100.62view
WEISS MICHAEL SExec. VC - Strategic Dev., 10% Owner 2014-11-06Buy1,000,000$1.61100.62view
Lu LucyCFO 2014-06-02Buy5,000$1.37135.77view
HORGAN KEVINFormer Chief Medical Officer 2014-04-22Sell47,566$1.8970.9view
HORGAN KEVINFormer Chief Medical Officer 2014-04-21Sell19,000$1.8178.45view
HORGAN KEVINFormer Chief Medical Officer 2014-04-17Sell101$1.8574.59view
Lu LucyCFO 2013-12-04Buy1,107$1.39132.37view

Press Releases about CNDO :

    Quarterly/Annual Reports about CNDO:

    News about CNDO:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight Jul 28 2013 
    Weekly CFO Buys Highlight Jul 21 2013 
    Weekly CFO Buys Highlight Jun 11 2013 
    Weekly CEO Buys Highlight: CNDO Jan 21 2013 
    Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K Jan 16 2013 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 


    More From Other Websites
    Nasdaq stocks posting largest volume increases Mar 04 2015
    Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology... Mar 04 2015
    TG Therapeutics Enters Into a Global Collaboration With Checkpoint Therapeutics to Develop and... Mar 04 2015
    Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology... Mar 04 2015
    TG Therapeutics Enters Into a Global Collaboration With Checkpoint Therapeutics to Develop and... Mar 04 2015
    Coronado Biosciences Closes $10 Million Private Placement Financing Mar 03 2015
    8:35 am Coronado Biosciences has closed a private placement of a promissory note for $10 mln Mar 03 2015
    Coronado Biosciences Closes $10 Million Private Placement Financing Mar 03 2015
    Coronado Biosciences (CNDO) Jumps: Stock Rises 10.7% - Tale of the Tape Feb 26 2015
    Coronado Biosciences In-Licenses Revogenex's Pain Drug - Analyst Blog Feb 19 2015
    Coronado Biosciences In-Licenses IV Tramadol, a Phase III Ready Asset, From Revogenex Ireland Ltd. Feb 18 2015
    Coronado Biosciences In-Licenses IV Tramadol, a Phase III Ready Asset, From Revogenex Ireland Ltd. Feb 18 2015
    Coronado Biosciences (CNDO) Looks Good: Stock Up 7.4% - Tale of the Tape Jan 19 2015
    Coronado Biosciences Reports on Separation of CB Pharma Acquisition Corp. Securities Jan 06 2015
    Coronado Biosciences Reports on Separation of CB Pharma Acquisition Corp. Securities Jan 06 2015
    Coronado Biosciences Announces Exercise of Portion of Over-Allotment Option in Conjunction With CB... Dec 29 2014
    Coronado Biosciences Announces Exercise of Portion of Over-Allotment Option in Conjunction With CB... Dec 29 2014
    Coronado Biosciences Announces Closing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 18 2014
    Coronado Biosciences Announces Closing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 18 2014
    Coronado Biosciences Announces Pricing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK